TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 93 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,779,158 | $32,149,385 | 4.73% |
| COWEN AND COMPANY, LLC | 1,999,383 | $36,128,850 | 3.00% |
| Vivo Capital, LLC | 2,262,200 | $40,877,954 | 2.82% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $32,300,613 | 1.93% |
| Cormorant Asset Management, LP | 1,421,422 | $25,685,096 | 1.44% |
| Sands Capital Ventures, LLC | 260,000 | $4,698,200 | 1.39% |
| Ghost Tree Capital, LLC | 150,000 | $2,710,500 | 0.90% |
| RTW INVESTMENTS, LP | 2,548,125 | $46,044,619 | 0.88% |
| Perceptive Advisors | 1,296,416 | $23,426,237 | 0.68% |
| TFG Asset Management GP Ltd | 165,000 | $2,981,550 | 0.40% |
| Grant/GrossMendelsohn, LLC | 53,625 | $938,974 | 0.38% |
| INNOVIS ASSET MANAGEMENT LLC | 13,141 | $237,458 | 0.09% |
| UBS OCONNOR LLC | 103,262 | $1,865,944 | 0.06% |
| Leucadia National | 355,758 | $6,428,547 | 0.06% |
| Sargent Investment Group, LLC | 10,045 | $181,513 | 0.04% |
| J. Goldman & Co LP | 55,972 | $1,011,414 | 0.04% |
| ALGERT GLOBAL LLC | 47,152 | $852 | 0.04% |
| ExodusPoint Capital Management, LP | 194,821 | $3,520 | 0.03% |
| Callan Capital, LLC | 14,750 | $266,533 | 0.03% |
| Channing Capital Management, LLC | 21,223 | $383,500 | 0.01% |
External links
This page lists TARSUS PHARMACEUTICALS INC's shareholders in Q2 2023. To view TARSUS PHARMACEUTICALS INC's shareholder history, click here.